Executive Summary
The Board denied Comcast’s request for Director Review of the Final Written Decision in the IPR concerning Entropic Communications’ patent 11,399,206. The denial applies to three related IPRs filed by the same parties.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Comcast Corporation et al. vs Entropic Communications LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Google LLCvsAdvanced Coding Technologies LLC
Google has filed an IPR petition challenging claims 1‑2 of U.S. Patent 9,986,303, asserting that the claims are obvious over earlier scalable video‑coding disclosures (Demircin, Chen, Karczewicz). The petition seeks institution of the review and argues that the prior art was not considered during prosecution.
Google LLCvsDialect LLC
Google LLC's attempt to invalidate Dialect LLC's speech recognition patent via IPR was denied by the PTAB. The Board found that Google failed to demonstrate a reasonable likelihood of success on its unpatentability grounds under 35 U.S.C. §§ 102 and 103. This decision maintains the validity of the '7398209 patent in the context of ongoing district court litigation.
Samsung Electronics Co., Ltd. et al.vsCerence Operating Company et al.
The PTAB institution decision found a reasonable likelihood of prevailing for Samsung against Cerence regarding claims related to voice messaging in mobile devices. The Board accepted the Petitioner's mapping that prior art discloses key elements, despite challenges from the Patent Owner on claim definitions.
Texas Instruments IncorporatedvsGreenthread, LLC
The Director granted review in multiple IPRs involving Texas Instruments and Greenthread, vacating the FWDs. The cases are remanded to allow discovery on privity issues across related proceedings.
Dexcom, Inc.vsAbbott Diabetes Care Inc.
Dexcom successfully petitioned to institute an IPR against Abbott Diabetes Care Inc.'s glucose monitoring patent (11298056). The Board found a reasonable likelihood of prevailing on grounds of obviousness (103) for claims 13 and 29.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.